Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...

LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...

The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Conference call and webcast to be held August 1, 2025 at 8:00 a.m. EDT ...